Fidaxomicin-Associated Hypersensitivity Reactions: Report of a Morbilliform Drug Eruption.

PurposeWe report a probable case of morbilliform drug eruption secondary to fidaxomicin in a patient with infection (CDI). A 62-year-old female presented to our institution's emergency department (ED) with symptoms consistent with infection. The patient was prescribed 2 weeks of oral vancomycin for CDI prior to presentation.